{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:27:36Z","timestamp":1770888456206,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T00:00:00Z","timestamp":1287532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Abalone has long been used as a valuable food source in East Asian countries. Although the nutritional importance of abalone has been reported through <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> studies, there is little evidence about the potential anti-tumor effects of abalone visceral extract. The aim of the present study is to examine anti-tumor efficacy of abalone visceral extract and to elucidate its working mechanism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In the present study, we used breast cancer model using BALB\/c mouse-derived 4T1 mammary carcinoma and investigated the effect of abalone visceral extract on tumor development. Inhibitory effect against tumor metastasis was assessed by histopathology of lungs. Cox-2 productions by primary and secondary tumor were measured by real-time RT-PCR and immunoblotting (IB). Proliferation assay based on [<jats:sup>3<\/jats:sup>H]-thymidine incorporation and measurement of cytokines and effector molecules by RT-PCR were used to confirm tumor suppression efficacy of abalone visceral extract by modulating cytolytic CD8+ T cells. The cytotoxicity of CD8<jats:sup>+<\/jats:sup> T cell was compared by JAM test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Oral administration of abalone visceral extract reduced tumor growth (tumor volume and weight) and showed reduced metastasis as confirmed by decreased level of splenomegaly (spleen size and weight) and histological analysis of the lung metastasis (gross analysis and histological staining). Reduced expression of Cox-2 (mRNA and protein) from primary tumor and metastasized lung was also detected. In addition, treatment of abalone visceral extract increased anti-tumor activities of CD8<jats:sup>+<\/jats:sup> T cells by increasing the proliferation capacity and their cytolytic activity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results suggest that abalone visceral extract has anti-tumor effects by suppressing tumor growth and lung metastasis through decreasing Cox-2 expression level as well as promoting proliferation and cytolytic function of CD8<jats:sup>+<\/jats:sup> T cells.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6882-10-60","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T18:14:48Z","timestamp":1287598488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Abalone visceral extract inhibit tumor growth and metastasis by modulating Cox-2 levels and CD8+ T cell activity"],"prefix":"10.1186","volume":"10","author":[{"given":"Choong-Gu","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Keun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Ha","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Rok","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae","family":"II Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin-Hyeog","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"337_CR1","unstructured":"Wikipedia contributors: Abalone [Internet]. Wikipedia TFEA, [cited 2009 Aug 7], [http:\/\/en.wikipedia.org\/w\/index.php?title=Abalone&oldid=306576568]"},{"key":"337_CR2","volume-title":"Journal of Applied Phycology","author":"E Hwang","year":"2009","unstructured":"Hwang E, Baek J, Park C: The mass cultivation of Ecklonia stolonifera Okamura as a summer feed for the abalone industry in Korea. Journal of Applied Phycology. 2009"},{"issue":"4","key":"337_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/B:JAPH.0000047783.36600.ef","volume":"16","author":"AJ Smit","year":"2004","unstructured":"Smit AJ: Medicinal and pharmaceutical uses of seaweed natural products: A review. Journal of Applied Phycology. 2004, 16 (4): 245-262. 10.1023\/B:JAPH.0000047783.36600.ef.","journal-title":"Journal of Applied Phycology"},{"issue":"6","key":"337_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00217-008-0890-2","volume":"227","author":"B-W Zhu","year":"2008","unstructured":"Zhu B-W, Wang L-S, Zhou D-Y, Li D-M, Sun L-M, Yang J-F, Wu H-T, Zhou X-Q, Tada M: Antioxidant activity of sulphated polysaccharide conjugates from abalone (Haliotis discus hannai Ino). European Food Research and Technology. 2008, 227 (6): 1663-1668. 10.1007\/s00217-008-0890-2.","journal-title":"European Food Research and Technology"},{"issue":"7","key":"337_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3746\/jkfn.2006.35.7.835","volume":"35","author":"HL Kim","year":"2006","unstructured":"Kim HL, Kang SG, Kim IC, Kim SJ, Kim DW, Ma SJ, Gao T, Li H, Kim MJ, Lee TH: In vitro Anti-hypertensive, Antioxidant and Anticoagulant Activities of Extracts from Haliotis discus hannai. Journal of The Korean Society of Food Science and Nutrition. 2006, 35 (7): 835-840. 10.3746\/jkfn.2006.35.7.835. Korean","journal-title":"Journal of The Korean Society of Food Science and Nutrition"},{"issue":"3","key":"337_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/ars.2007.1740","volume":"10","author":"N Khan","year":"2008","unstructured":"Khan N, Afaq F, Mukhtar H: Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise. Antioxidants & Redox Signaling. 2008, 10 (3): 475-510.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"3","key":"337_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF00205631","volume":"24","author":"H Uchida","year":"1987","unstructured":"Uchida H, Sasaki T, Uchida NA, Takasuka N, Endo Y, Kamiya H: Oncostatic and immunomodulatory effects of a glycoprotein fraction from water extract of abalone, Haliotis discus hannai. Cancer Immunology, Immunotherapy. 1987, 24 (3): 207-212. 10.1007\/BF00205631.","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"2","key":"337_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer Statistics, 2008. CA Cancer J Clin. 2008, 58 (2): 71-96. 10.3322\/CA.2007.0010.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"337_CR9","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.1996.14.8.2197","volume":"14","author":"PA Greenberg","year":"1996","unstructured":"Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU: Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996, 14 (8): 2197-2205.","journal-title":"J Clin Oncol"},{"issue":"11","key":"337_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M: Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2. N Engl J Med. 2001, 344 (11): 783-792. 10.1056\/NEJM200103153441101.","journal-title":"N Engl J Med"},{"issue":"S1","key":"337_CR11","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1079\/BJN20061699","volume":"96","author":"CA Gonzalez","year":"2006","unstructured":"Gonzalez CA: Nutrition and cancer: the current epidemiological evidence. British Journal of Nutrition. 2006, 96 (S1): S42-S45.","journal-title":"British Journal of Nutrition"},{"issue":"1","key":"337_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1475-2891-3-19","volume":"3","author":"M Donaldson","year":"2004","unstructured":"Donaldson M: Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutrition Journal. 2004, 3 (1): 19-10.1186\/1475-2891-3-19.","journal-title":"Nutrition Journal"},{"issue":"20","key":"337_CR13","first-page":"5727","volume":"62","author":"X Huang","year":"2002","unstructured":"Huang X, Wong MK, Yi H, Watkins S, Laird AD, Wolf SF, Gorelik E: Combined Therapy of Local and Metastatic 4T1 Breast Tumor in Mice Using SU6668, an Inhibitor of Angiogenic Receptor Tyrosine Kinases, and the Immunostimulator B7.2-IgG Fusion Protein. Cancer Res. 2002, 62 (20): 5727-5735.","journal-title":"Cancer Res"},{"issue":"7","key":"337_CR14","first-page":"1486","volume":"58","author":"BA Pulaski","year":"1998","unstructured":"Pulaski BA, Ostrand-Rosenberg S: Reduction of Established Spontaneous Mammary Carcinoma Metastases following Immunotherapy with Major Histocompatibility Complex Class II and B7.1 Cell-based Tumor Vaccines. Cancer Res. 1998, 58 (7): 1486-1493.","journal-title":"Cancer Res"},{"issue":"2","key":"337_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2009.01.015","volume":"278","author":"K Ho-Keun","year":"2009","unstructured":"Ho-Keun K, Won Kyung J, Ji-Sun H, Choong-Gu L, Jae-Seon S, Jin AP, Byoung Seob K, Sin-Hyeog I: Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells. Cancer letters. 2009, 278 (2): 174-182. 10.1016\/j.canlet.2009.01.015.","journal-title":"Cancer letters"},{"issue":"2","key":"337_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nprot.2006.107","volume":"1","author":"D Usharauli","year":"2006","unstructured":"Usharauli D, Perez-Diez A, Matzinger P: The JAM Test and its daughter P-JAM: simple tests of DNA fragmentation to measure cell death and stasis. Nat Protocols. 2006, 1 (2): 672-682. 10.1038\/nprot.2006.107.","journal-title":"Nat Protocols"},{"issue":"1","key":"337_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/1097-0142(19870701)60:1<100::AID-CNCR2820600118>3.0.CO;2-9","volume":"60","author":"K Baruch","year":"1987","unstructured":"Baruch K, Moshe S, Abraham K, Marianne S, Dany B, Eliezer R, David G: Splenomegaly and solitary spleen metastasis in solid tumors. Cancer. 1987, 60 (1): 100-102. 10.1002\/1097-0142(19870701)60:1<100::AID-CNCR2820600118>3.0.CO;2-9.","journal-title":"Cancer"},{"issue":"1","key":"337_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","volume":"82","author":"SA duPre","year":"2007","unstructured":"duPre SA, Hunter JKW: Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factors. Experimental and Molecular Pathology. 2007, 82 (1): 12-24. 10.1016\/j.yexmp.2006.06.007.","journal-title":"Experimental and Molecular Pathology"},{"issue":"6824","key":"337_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410 (6824): 50-56. 10.1038\/35065016.","journal-title":"Nature"},{"issue":"7137","key":"337_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nature05760","volume":"446","author":"GP Gupta","year":"2007","unstructured":"Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova-Todorova K, Massague J: Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature. 2007, 446 (7137): 765-770. 10.1038\/nature05760.","journal-title":"Nature"},{"issue":"14","key":"337_CR21","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1158\/0008-5472.CAN-08-4619","volume":"69","author":"PB Olkhanud","year":"2009","unstructured":"Olkhanud PB, Baatar D, Bodogai M, Hakim F, Gress R, Anderson RL, Deng J, Xu M, Briest S, Biragyn A: Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells. Cancer Res. 2009, 69 (14): 5996-6004. 10.1158\/0008-5472.CAN-08-4619.","journal-title":"Cancer Res"},{"issue":"3","key":"337_CR22","first-page":"632","volume":"62","author":"A Ristimaki","year":"2002","unstructured":"Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J: Prognostic Significance of Elevated Cyclooxygenase-2 Expression in Breast Cancer. Cancer Res. 2002, 62 (3): 632-635.","journal-title":"Cancer Res"},{"issue":"11","key":"337_CR23","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1093\/carcin\/bgn202","volume":"29","author":"JR Neil","year":"2008","unstructured":"Neil JR, Johnson KM, Nemenoff RA, Schiemann WP: Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. Carcinogenesis. 2008, 29 (11): 2227-2235. 10.1093\/carcin\/bgn202.","journal-title":"Carcinogenesis"},{"issue":"2","key":"337_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1734-1140(10)70262-0","volume":"62","author":"N Ghosh","year":"2010","unstructured":"Ghosh N, Chaki R, Mandal V, Mandal SC: COX-2 as a target for cancer chemotherapy. Pharmacol Rep. 2010, 62 (2): 233-244.","journal-title":"Pharmacol Rep"},{"issue":"6","key":"337_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc1093","volume":"3","author":"G Bergers","year":"2003","unstructured":"Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003, 3 (6): 401-410. 10.1038\/nrc1093.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"337_CR26","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1038\/sj.onc.1210154","volume":"26","author":"B Singh","year":"2007","unstructured":"Singh B, Berry JA, Shoher A, Ayers GD, Wei C, Lucci A: COX-2 involvement in breast cancer metastasis to bone. Oncogene. 2007, 26 (26): 3789-3796. 10.1038\/sj.onc.1210154.","journal-title":"Oncogene"},{"issue":"7050","key":"337_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature. 2005, 436 (7050): 518-524. 10.1038\/nature03799.","journal-title":"Nature"},{"issue":"1","key":"337_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2407-8-83","volume":"8","author":"B Zhang","year":"2008","unstructured":"Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y: Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer. BMC Cancer. 2008, 8 (1): 83-10.1186\/1471-2407-8-83.","journal-title":"BMC Cancer"},{"issue":"1","key":"337_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2407-6-181","volume":"6","author":"T Larkins","year":"2006","unstructured":"Larkins T, Nowell M, Singh S, Sanford G: Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer. 2006, 6 (1): 181-10.1186\/1471-2407-6-181.","journal-title":"BMC Cancer"},{"issue":"5","key":"337_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc1613","volume":"5","author":"RA Lake","year":"2005","unstructured":"Lake RA, Robinson BWS: Immunotherapy and chemotherapy - a practical partnership. Nat Rev Cancer. 2005, 5 (5): 397-405. 10.1038\/nrc1613.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"337_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani JA, Smyth MJ: Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol. 2002, 2 (10): 735-747. 10.1038\/nri911.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"337_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1252","volume":"4","author":"G Dranoff","year":"2004","unstructured":"Dranoff G: Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004, 4 (1): 11-22. 10.1038\/nrc1252.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"337_CR33","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nri1490","volume":"4","author":"LH Glimcher","year":"2004","unstructured":"Glimcher LH, Townsend MJ, Sullivan BM, Lord GM: Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol. 2004, 4 (11): 900-911. 10.1038\/nri1490.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"337_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1470-2045(03)01220-8","volume":"4","author":"G Gasparini","year":"2003","unstructured":"Gasparini G, Longo R, Sarmiento R, Morabito A: Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?. The Lancet Oncology. 2003, 4 (10): 605-615. 10.1016\/S1470-2045(03)01220-8.","journal-title":"The Lancet Oncology"},{"issue":"3","key":"337_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1054\/bjoc.2000.1270","volume":"83","author":"S Tomozawa","year":"2000","unstructured":"Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, Saito S, Tsuruo T, Shibata Y, Nagawa H: Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. British Journal of Cancer. 2000, 83 (3): 324-328. 10.1054\/bjoc.2000.1270.","journal-title":"British Journal of Cancer"},{"issue":"8","key":"337_CR36","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1200\/JCO.2005.12.017","volume":"23","author":"BP Schneider","year":"2005","unstructured":"Schneider BP, Miller KD: Angiogenesis of Breast Cancer. J Clin Oncol. 2005, 23 (8): 1782-1790. 10.1200\/JCO.2005.12.017.","journal-title":"J Clin Oncol"},{"issue":"3","key":"337_CR37","first-page":"625","volume":"62","author":"KM Leahy","year":"2002","unstructured":"Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL: Cyclooxygenase-2 Inhibition by Celecoxib Reduces Proliferation and Induces Apoptosis in Angiogenic Endothelial Cells in Vivo. Cancer Res. 2002, 62 (3): 625-631.","journal-title":"Cancer Res"},{"issue":"4","key":"337_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc1586","volume":"5","author":"W Zou","year":"2005","unstructured":"Zou W: Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005, 5 (4): 263-274. 10.1038\/nrc1586.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"337_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00432-003-0459-1","volume":"129","author":"P W\u00fclfing","year":"2003","unstructured":"W\u00fclfing P, Diallo R, M\u00fcller C, W\u00fclfing C, Poremba C, Heinecke A, Rody A, Greb RR, B\u00f6cker W, Kiesel L: Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis. Journal of Cancer Research and Clinical Oncology. 2003, 129 (7): 375-382. 10.1007\/s00432-003-0459-1.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"1","key":"337_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/gut.2004.047100","volume":"55","author":"D Wang","year":"2006","unstructured":"Wang D, DuBois RN: PROSTAGLANDINS AND CANCER. Gut. 2006, 55 (1): 115-122. 10.1136\/gut.2004.047100.","journal-title":"Gut"},{"issue":"2","key":"337_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1006689719505","volume":"17","author":"M Lelekakis","year":"1999","unstructured":"Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J: A novel orthotopic model of breast cancer metastasis to bone. Clinical and Experimental Metastasis. 1999, 17 (2): 163-170. 10.1023\/A:1006689719505.","journal-title":"Clinical and Experimental Metastasis"},{"issue":"2","key":"337_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.bjc.6600462","volume":"87","author":"EM Connolly","year":"2002","unstructured":"Connolly EM, Harmey JH, O'Grady T, Foley D, Roche-Nagle G, Kay E, Bouchier-Hayes DJ: Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. Br J Cancer. 2002, 87 (2): 231-237. 10.1038\/sj.bjc.6600462.","journal-title":"Br J Cancer"},{"issue":"6","key":"337_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jcp.55.6.429","volume":"55","author":"C Costa","year":"2002","unstructured":"Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC: Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 2002, 55 (6): 429-434.","journal-title":"J Clin Pathol"},{"issue":"3","key":"337_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJM, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A: The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009, 30 (3): 377-386. 10.1093\/carcin\/bgp014.","journal-title":"Carcinogenesis"},{"issue":"1","key":"337_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/CCO.0b013e32831bc38a","volume":"21","author":"MJ Pittet","year":"2009","unstructured":"Pittet MJ: Behavior of immune players in the tumor microenvironment. Current Opinion in Oncology. 2009, 21 (1): 53-59. 10.1097\/CCO.0b013e32831bc38a.","journal-title":"Current Opinion in Oncology"},{"issue":"8","key":"337_CR46","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1158\/0008-5472.CAN-03-3066","volume":"64","author":"A Zippelius","year":"2004","unstructured":"Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Lienard D, Lejeune F, Rimoldi D, Guillaume P, Meidenbauer N, Mackensen A: Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance. Cancer Res. 2004, 64 (8): 2865-2873. 10.1158\/0008-5472.CAN-03-3066.","journal-title":"Cancer Res"},{"issue":"9","key":"337_CR47","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.4049\/jimmunol.167.9.5042","volume":"167","author":"S Radoja","year":"2001","unstructured":"Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, Frey AB: CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis. J Immunol. 2001, 167 (9): 5042-5051.","journal-title":"J Immunol"},{"issue":"3","key":"337_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2249.1997.4771375.x","volume":"109","author":"LE Van Den Hove","year":"1997","unstructured":"Van Den Hove LE, Van Gool SW, Van Poppel H, Baert L, Coorevits L, Van Damme B, Ceuppens JL: Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Clinical & Experimental Immunology. 1997, 109 (3): 501-509.","journal-title":"Clinical & Experimental Immunology"},{"issue":"3","key":"337_CR49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ijc.2910630311","volume":"63","author":"H Nakagomi","year":"1995","unstructured":"Nakagomi H: Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. International Journal of Cancer. 1995, 63 (3): 366-371. 10.1002\/ijc.2910630311.","journal-title":"International Journal of Cancer"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-10-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-10-60\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-10-60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-10-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:43:17Z","timestamp":1630471397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-10-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["337"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-10-60","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,20]]},"assertion":[{"value":"19 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}